Ajanta Pharma Ltd Quarterly Results

Gross Sales

1,170.41

1,146.13

1,186.64

1,144.92

1,054.08

Excise Duty

0

0

0

0

0

Net Sales

1,170.41

1,146.13

1,186.64

1,144.92

1,054.08

Other Operating Income

0

0

0

0

0

Other Income

18.11

30.44

19.48

26.47

35.5

Total Income

1,188.52

1,176.57

1,206.12

1,171.39

1,089.58

Total Expenditure

873.26

825.3

875.47

814.57

775.76

PBIDT

315.26

351.27

330.65

356.82

313.82

Interest

6.07

7.91

6.02

0.73

1.53

PBDT

309.19

343.36

324.63

356.09

312.29

Depreciation

39.78

35.97

34.39

33.97

34.25

Minority Interest Before NP

0

0

0

0

0

Tax

61.96

94.85

76.11

79.38

73.11

Deferred Tax

-17.81

-20.34

-2.35

-3.03

2.21

Reported Profit After Tax

225.26

232.88

216.48

245.77

202.72

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

225.26

232.88

216.48

245.77

202.72

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

225.26

232.88

216.48

245.77

202.72

EPS (Unit Curr.)

18

18.6

17.27

19.54

16.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

1,400

0

0

Equity

25.07

25.07

25.07

25.07

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.93

30.64

27.86

31.16

29.77

PBDTM(%)

26.41

29.95

27.35

31.1

29.62

PATM(%)

19.24

20.31

18.24

21.46

19.23